All stocks ยท JUBLPHARMA
JP

JUBILANT PHARMOVA LIMITED

JUBLPHARMA BSE Healthcare

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development โ€ฆ

ISIN INE700A01033
Listed โ€”
Quarters tracked 13
Filings 20 docs

About

Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of pulmonary embolism, cancer, coronary artery disease, and other diseases. Its Allergy Immunotherapy segment provides specialized diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacture, distribution, sale, and marketing of generic formulations for therapeutic areas, such as cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment provides drug discovery services and active pharmaceutical ingredients. Its Proprietary Novel Drugs segment offers patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organizations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida, India.

Key Metrics

as of Sep 2026
Market Cap14,752 Cr
P/E38.00
Div Yield0.54 %
Book Valueโ‚น445.00
52w Highโ‚น1,185.00
52w Lowโ‚น784.00
Face Valueโ‚น1.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 2,229.00 2,290.00 2,122.00 1,966.00 1,901.00 1,929.00 1,822.00 1,752.00 1,732.00 1,759.00 1,677.00 1,680.00 1,587.00
Expenses 1,981.00 1,951.00 1,833.00 1,625.00 1,611.00 1,584.00 1,535.00 1,463.00 1,480.00 1,487.00 1,459.00 1,438.00 1,419.00
Operating Profit 248.00 339.00 289.00 341.00 290.00 345.00 287.00 289.00 252.00 271.00 218.00 242.00 168.00
OPM % 11.00 15.00 14.00 17.00 15.00 18.00 16.00 17.00 15.00 15.00 13.00 14.00 11.00
Other Income 20.00 10.00 -19.00 4.00 12.00 9.00 -10.00 8.00 410.00 -151.00 49.00 19.00 9.00
Depreciation 127.00 117.00 121.00 105.00 98.00 95.00 91.00 91.00 91.00 101.00 95.00 97.00 90.00
Interest 54.00 56.00 56.00 50.00 49.00 53.00 56.00 61.00 71.00 73.00 71.00 66.00 62.00
Profit before tax 86.00 176.00 93.00 190.00 154.00 206.00 130.00 144.00 500.00 -54.00 101.00 98.00 25.00
Tax % 35.00 32.00 40.00 37.00 34.00 27.00 23.00 29.00 4.00 15.00 34.00 37.00 76.00
Net Profit 56.00 119.00 56.00 120.00 102.00 151.00 101.00 102.00 482.00 -62.00 66.00 62.00 6.00
EPS in Rs 3.55 7.50 3.51 7.55 6.46 9.64 6.33 6.45 30.26 -3.68 4.19 3.92 0.40

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 8,280.007,234.006,703.006,282.006,130.006,099.005,976.009,111.007,518.005,861.005,749.005,751.00
Expenses 7,020.006,061.005,802.005,503.004,980.004,695.004,428.007,367.005,995.004,510.004,493.005,141.00
Operating Profit 1,260.001,173.00901.00779.001,150.001,403.001,548.001,744.001,522.001,352.001,256.00610.00
OPM % 15.0016.0013.0012.0019.0023.0026.0019.0020.0023.0022.0011.00
Other Income 7.00416.00-76.00-9.008.00263.00225.00-249.0036.0019.004.0086.00
Interest 212.00240.00272.00188.00145.00184.00200.00220.00284.00341.00371.00368.00
Depreciation 440.00369.00382.00554.00382.00349.00340.00371.00415.00291.00347.00288.00
Profit before tax 614.00981.00170.0028.00630.001,133.001,233.00904.00859.00738.00542.0040.00
Tax % 35.0015.0057.00333.0034.0026.0027.0036.0026.0022.0029.00200.00
Net Profit 398.00836.0073.00-65.00413.00836.00898.00577.00634.00575.00387.00-40.00
EPS in Rs 25.0252.694.84-3.8325.9852.4756.3936.0640.3536.1424.60-3.63
Dividend Payout % 20.009.00102.00-130.0019.0010.009.0012.007.008.0012.00-83.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 16.0016.0016.0016.0016.0016.0016.0016.0016.0016.0016.0016.00
Reserves 7,077.006,239.005,418.005,383.005,303.004,726.005,588.004,793.004,071.003,420.002,951.002,438.00
Borrowings 3,615.002,731.003,664.003,677.003,192.002,830.004,808.004,840.003,469.004,045.004,493.004,793.00
Other Liabilities 4,564.003,598.002,240.001,853.001,319.001,192.001,898.001,670.001,902.001,417.001,280.001,372.00
Total Liabilities 15,272.0012,584.0011,338.0010,929.009,830.008,763.0012,310.0011,319.009,457.008,899.008,740.008,619.00
Fixed Assets 6,966.005,176.005,091.005,183.004,871.004,609.006,340.005,648.005,401.005,107.005,104.004,911.00
CWIP 4,040.003,630.002,103.001,562.001,090.00897.00768.00901.00671.00684.00611.00597.00
Investments 61.0044.0042.00256.00239.00241.0069.00115.00124.00103.0085.0040.00
Other Assets 4,205.003,735.004,101.003,928.003,631.003,017.005,133.004,654.003,262.003,006.002,939.003,071.00
Total Assets 15,272.0012,584.0011,338.0010,929.009,830.008,763.0012,310.0011,319.009,457.008,899.008,740.008,619.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 1,227.001,072.00971.00661.00838.001,784.001,543.001,122.001,303.001,268.001,099.00783.00
Cash from Investing Activity -1,143.00512.00-596.00-474.00-323.00-727.00-267.00-1,018.00-614.00-465.00-309.00-362.00
Cash from Financing Activity 95.00-1,453.00-432.00-157.00-33.00-1,709.00-1,050.00657.00-901.00-686.00-843.00-503.00
Net Cash Flow 179.00132.00-58.0030.00482.00-652.00225.00761.00-212.00117.00-52.00-82.00
Free Cash Flow -120.00-38.0083.00-135.00241.001,270.00975.00473.00819.00806.00760.00434.00
CFO/OP % 114.00112.00131.00111.0090.00155.00116.0084.00103.00104.0091.00141.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 47.0045.0050.0056.0055.0049.0079.0051.0055.0063.0060.0052.00
Inventory Days 170.00178.00220.00268.00308.00268.00463.00147.00177.00223.00207.00169.00
Days Payable 170.00158.00146.00160.00139.00124.00273.00106.00145.00137.00106.0099.00
Cash Conversion Cycle 47.0065.00124.00165.00224.00194.00268.0092.0087.00149.00162.00122.00
Working Capital Days 13.0016.0056.0057.0056.0074.0062.0045.0045.0050.004.0012.00
ROCE % 9.0010.007.003.0010.0012.0015.0016.0015.0015.0013.006.00

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 47.67 47.67 47.67 47.67 47.67 50.67 50.67 50.67 50.67 50.67 50.67 50.67
FIIs 15.87 15.90 15.96 16.56 17.40 17.23 16.96 17.94 19.50 19.06 20.29 23.20
DIIs 12.40 11.63 11.23 10.53 9.52 7.05 6.99 5.66 4.06 3.77 2.89 1.64
Public 23.50 24.25 24.57 24.60 24.83 24.48 24.82 25.17 25.18 25.91 25.56 23.89
No. of Shareholders 82,703 86,347 90,133 93,336 99,673 96,526 102,442 89,456 81,992 92,264 86,588 89,376

Corporate Actions

28 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 24 Jul 2026 24 Jul 2026 โ€” 5.00
Dividend 25 Jul 2025 25 Jul 2025 โ€” 5.00
Dividend 02 Aug 2024 02 Aug 2024 โ€” 5.00
Dividend 10 Aug 2023 10 Aug 2023 โ€” 5.00
Dividend 11 Aug 2022 12 Aug 2022 โ€” 5.00
Dividend 05 Aug 2021 06 Aug 2021 โ€” 5.00
Other 04 Feb 2021 05 Feb 2021 โ€” โ€” Spin Off
Other 04 Feb 2021 05 Feb 2021 โ€” โ€” Demerger
Dividend 09 Mar 2020 11 Mar 2020 โ€” 5.00
Dividend 12 Sep 2019 โ€” โ€” 4.50
Dividend 12 Sep 2018 โ€” โ€” 3.00
Dividend 16 Aug 2017 โ€” โ€” 3.00
Dividend 18 Aug 2016 โ€” โ€” 3.00
Dividend 20 Aug 2015 โ€” โ€” 3.00
Dividend 21 Aug 2014 โ€” โ€” 3.00
Dividend 14 Aug 2013 โ€” โ€” 3.00
Dividend 14 Aug 2012 โ€” โ€” 3.00
Dividend 10 Aug 2011 โ€” โ€” 2.00
Other 25 Nov 2010 26 Nov 2010 โ€” โ€” Scheme of Arrangement
Other 25 Nov 2010 26 Nov 2010 โ€” โ€” Scheme Of Demerger
Dividend 17 Sep 2010 โ€” โ€” 2.00
Dividend 29 Jun 2009 โ€” โ€” 1.50
Other 29 Jun 2009 โ€” โ€” โ€” Dividend-Rs.1.50 Pr Share
Dividend 17 Sep 2008 โ€” โ€” 1.50
Dividend 17 Sep 2007 โ€” โ€” 1.25
Dividend 08 Sep 2006 โ€” โ€” 1.25
Dividend 22 Aug 2005 โ€” โ€” 6.25
Dividend 28 Aug 2001 โ€” โ€” 6.00

Announcements

5 filings